UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Motor neuron syndromes in cancer patients

Annals of neurology, 1997-06, Vol.41 (6), p.722-730

1997

Volltextzugriff (PDF)

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

Neurology, 2016-11, Vol.87 (20), p.2123-2131

2016

Volltextzugriff (PDF)

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

Lancet neurology, 2010, Vol.9 (1), p.77-93

2010

Volltextzugriff (PDF)

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

Neurology, 1998-01, Vol.50 (1), p.72-77

1998

Volltextzugriff (PDF)

Corticosteroids in Duchenne muscular dystrophy: Major variations in practice

Muscle & nerve, 2013-07, Vol.48 (1), p.27-31

2013

Volltextzugriff (PDF)

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

Neurology, 1993-03, Vol.43 (3 Pt 1), p.520-520

1993

Volltextzugriff (PDF)

DISORDERS OF LIPID METABOLISM IN SKELETAL MUSCLE

Neurologic clinics, 2000-02, Vol.18 (1), p.167-184

Cwik, Valerie A.

2000

Volltextzugriff (PDF)

Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?

Neurology, 2013-02, Vol.80 (6), p.583-589

2013

Volltextzugriff (PDF)

T.P.5.01 Phase 2b Study of PTC124 in Duchenne/Becker muscular dystrophy (DMD/BMD): Demographic and other baseline data

Neuromuscular disorders : NMD, 2008-10, Vol.18 (9), p.823-823

2008

Volltextzugriff (PDF)

Distal vacuolar myopathy in nephropathic cystinosis

Annals of neurology, 1994-02, Vol.35 (2), p.181-188

1994

Volltextzugriff (PDF)

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Bone marrow transplantation (Basingstoke), 1997-05, Vol.19 (9), p.939-942

1997

Volltextzugriff (PDF)

Perspectives on best practices for gene therapy programs

Human gene therapy, 2015-03, Vol.26 (3), p.127-133

2015

Volltextzugriff (PDF)

Guidelines and Outcomes; Standardizing Care for Duchenne Muscular Dystrophy (P04.087)

Neurology, 2012-04, Vol.78 (Meeting Abstracts 1), p.P04-P04.087

2012

Volltextzugriff (PDF)

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy

Neurology, 1993-03, Vol.43 (3 Pt 1), p.532-532

1993

Volltextzugriff (PDF)

The prevalence of motor neurone disease in the Province of Alberta

Canadian journal of neurological sciences, 1999-05, Vol.26 (2), p.119

1999

Volltextzugriff (PDF)

Carrier testing for spinal muscular atrophy

Genetics in medicine, 2010-10, Vol.12 (10), p.621-622

2010

Volltextzugriff (PDF)

Disorders of lipid metabolism in skeletal muscle: Metabolic myopathies

Neurologic clinics, 2000, Vol.18 (1)

CWIK, V. A

2000

Volltextzugriff (PDF)

Mild hypothermia preserves contractile function and inhibits prostaglandin E2 release from metabolically stressed skeletal muscle

Canadian journal of neurological sciences, 1994-05, Vol.21 (2), p.120

1994

Volltextzugriff (PDF)

Relationship of oxypurine release to contractile failure in dinitrophenol-treated rat skeletal muscle

Acta physiologica Scandinavica, 1993-11, Vol.149 (3), p.249-255

1993

Volltextzugriff (PDF)

Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD/ENMC Workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD Workshop on outcome measures in experimental trials for DMD, 30th June–1st July 2007, Naarden, The Netherlands; Conjoint Institute of Myology TREAT-NMD Meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France

Neuromuscular disorders : NMD, 2008-11, Vol.18 (11), p.894-903

2008

Volltextzugriff (PDF)

Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis

Journal of the neurological sciences, 2002-06, Vol.198 (1), p.37-41

2002

Volltextzugriff (PDF)

Andersen's syndrome with absent tubular aggregates in muscle biopsy

Neuromuscular disorders : NMD, 1997-09, Vol.7 (6), p.448-448

1997

Volltextzugriff (PDF)

Neurotrophic factors decrease the release of creatine kinase and prostaglandin E2 from metabolically stressed muscle

Neuromuscular disorders : NMD, 1998-02, Vol.8 (1), p.7-13

1998

Volltextzugriff (PDF)

Bruxism following cerebellar hemorrhage

Neurology, 1989-09, Vol.39 (9), p.1262-1262

1989

Volltextzugriff (PDF)

Evidence of two mechanisms of prostaglandin release in an in vitro model of muscle damage. Possible therapeutic implications

Neuromuscular disorders : NMD, 1994-09, Vol.4 (5), p.483-488

1994

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Englisch
(88)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Physical Sciences
(25)
Physics
(23)
Humans
(22)
Life Sciences & Biomedicine
(22)
Technology
(21)
Magnetic Fields
(18)
Materials Science
(17)
Male
(16)
Biological And Medical Sciences
(15)
Materials Science, Multidisciplinary
(14)
Medical Sciences
(14)
Neurosciences & Neurology
(14)
Clinical Neurology
(12)
Magnetic Properties
(11)
Neurology
(11)
Phase Transitions
(11)
Magnetism
(10)
Magnetocaloric Effect
(10)
Physics, Applied
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Motor neuron syndromes in cancer patients

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

Corticosteroids in Duchenne muscular dystrophy: Major variations in practice

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

DISORDERS OF LIPID METABOLISM IN SKELETAL MUSCLE

Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?

T.P.5.01 Phase 2b Study of PTC124 in Duchenne/Becker muscular dystrophy (DMD/BMD): Demographic and other baseline data

Distal vacuolar myopathy in nephropathic cystinosis

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Perspectives on best practices for gene therapy programs

Guidelines and Outcomes; Standardizing Care for Duchenne Muscular Dystrophy (P04.087)

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy

The prevalence of motor neurone disease in the Province of Alberta

Carrier testing for spinal muscular atrophy

Disorders of lipid metabolism in skeletal muscle: Metabolic myopathies

Mild hypothermia preserves contractile function and inhibits prostaglandin E2 release from metabolically stressed skeletal muscle

Relationship of oxypurine release to contractile failure in dinitrophenol-treated rat skeletal muscle

Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis

Andersen's syndrome with absent tubular aggregates in muscle biopsy

Neurotrophic factors decrease the release of creatine kinase and prostaglandin E2 from metabolically stressed muscle

Bruxism following cerebellar hemorrhage

Evidence of two mechanisms of prostaglandin release in an in vitro model of muscle damage. Possible therapeutic implications

Suchergebnisse filtern